Precision DTIL 深 沪
等待开盘 05-12 09:30:00 美东时间
7.86
+0.190
+2.48%
华盛通- 最 高8.19
- 今 开7.68
- 成交量 18.99万股
- 最 低 7.21
- 昨 收 7.67
- 总市值 48.87万
- 52周最高 8.8169
- 市盈率 静 --
- 换手率 305.38%
- 52周最低 3.53
- 委 比 -22.78%
- 总股本 6.22万
- 历史最高 23.67
- 量 比 0.94
- 振 幅 12.78%
- 历史最低 0.275
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Madrigal Pharmaceuticals Announces Exclusive Global License Agreement With Arrowhead Pharmaceuticals For ARO-PNPLA3
Company advances its leadership in MASH with clinical-stage, genetically targeted siRNA asset from Arrowhead PharmaceuticalsPrecision approach targets patients who have a mutation in the PNPLA3 gene, which is highly
05-05 20:02
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Precision BioSciences Lands $7.5M Milestone Payment From TG Therapeutics In MS Drug Trial
Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today
03-02 20:12
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Precision BioSciences Secures $13M From Imugene Convertible Note Maturity As Part of Azer-cel Deal
Precision BioSciences Secures $13M From Imugene Convertible Note Maturity As Part of Azer-cel Deal
2024-09-03 19:27
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60 price target.
2024-08-23 00:19
